and initial use of substances, but that genetic factors have a major influence on progression of use to dependence. To the extent this is true, the expression of genetic risk would be more closely associated with the final stage of progression to an AD diagnosis than with earlier stages. One could speculate that it is the common genetic variance shared by psychiatric disorders and AD that influences the final stage of progression to AD, and that the earlier stages are less genetically and more environmentally determined.
